FDA chief Scott Gottlieb steps down after nearly 2 years
(AP Photo/J. Scott Applewhite, File) In this Wednesday, April 5, 2017, file photo, Dr. Scott Gottlieb speaks during his confirmation hearing before a Senate committee, in Washington, as President Donald Trump's nominee to head the Food and Drug Administration. Gottlieb is stepping down after nearly two years leading the agency’s response to a host of public health challenges, including the opioid epidemic, rising drug prices and underage vaping.
Washington • Food and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency’s response to a host of public health challenges, including the opioid epidemic, rising drug prices and underage vaping.
Health and Human Services Secretary Alex Azar announced Gottlieb's planned resignation in a statement Tuesday.
President Donald Trump tapped Gottlieb in 2017 to "cut red tape" at the FDA.
Gottlieb bucked expectations by pushing the agency to expand its authorities in several key ways, including an unprecedented effort to make cigarettes less addictive by requiring lower nicotine levels.
More recently, Gottlieb has been criticized for not acting sooner to address an explosion in teenage use of e-cigarettes.
sltrib.com is now free to access — no subscription required. We made this decision because we believe access to trustworthy, independent news shouldn’t depend on what you can afford — especially as misinformation and AI-generated content continue to rise.
Free to read doesn’t mean free to produce. Our reporters show up every day to ask hard questions and hold powerful institutions to account. That work takes resources. As a nonprofit newsroom, we rely on support from people who believe it matters. Make a donation today to fund local news that serves Utah communities.
You can help us bring more local news to more communities today.